Paydirt
MO
Insider

Mark Van Oene

See Remarks · Pacific Biosciences of California

Mark Van Oene (See Remarks) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Pacific Biosciences of California, Inc. (PACB). The largest single filing was $205K of PACB (129,790 sh × $1.58, as filed), executed Feb 17. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$205K
shares × price, as filed
Last traded
Feb 17
Filed Feb 19

Median ADV $23.2M across their filed names

Open performance→
Volume by month
$205K$103K$0Dec 2024Jun 2025Dec 2025Jun 2026Feb 2025 · sells $189KFeb 2026 · sells $205K
Buys $0 Sells $395K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
PACB Pacific Biosciences of California, Inc. PACB · 0 buys · 2 sells 2 filings
Recent filings
PACBSALE Pacific Biosciences of California, Inc. View filing → $205K
129,790 sh × $1.58
Exec Feb 17
Filed Feb 19 · 5:30 PM ET
PACBSALE Pacific Biosciences of California, Inc. View filing → $189K
100,773 sh × $1.88
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET